There are many interesting observations that can be summarised...

There are many interesting observations that can be summarised to give perspective on ADO battery position.

• ADO had data like ATC in 2014/15 that showed the significant potential of ADO glue in battery applications.
• The ADO glue technology is symbiotic across applications and separation of business lines would lose the benefits of the technology into new applications - a key fundamental of ADO.
• Harnessing that reliably and testing in 3rd party materials has taken 5 years - expected and slowed because of Covid-19
• Value will not be properly recognised until a deal is done.
• The battery application can look to say 50% Si anode - assuming no cathode rate limiting issues then possible over 2,000mAh/g - that means well over 1,000km range for cars for example.
• Life Science - Eugeni (europium) and Ellume (q dots) provide clear proof of ADO glue functionality in managing different disparate and difficult situations at the nano level. The battery application (Si expansion issues) is further fundamental proof.
• This over night success is now 21 years into its development and a lot more is to come.
• The Eugeni Covid-19 test is only a commercial proof of concept, the tip of the iceberg, the low cost of development - sensitivity - accuracy - stability will progress across an increasing array of gold standard tests putting ADO at the leading edge of POC providing profitable low cost quantitative testing to rich and poor economies alike.
• ADO is nearly across the financial chasm. Once real revenue starts (patience) the long term view will accelerate.